Advertisement
Screener

X4 PHARMACEUTICALS, INC (XFOR) Other

X4 PHARMACEUTICALS, INC Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2024-03-21: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock · XFOR · NASDAQ.
  • 2023-11-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · XFOR · NASDAQ.
  • 2023-08-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · XFOR · NASDAQ.
  • 2023-05-04: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · XFOR · NASDAQ.
FiledFormItemAs filed
2024-03-2110-KStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2023-11-0910-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2023-08-1010-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2023-05-0410-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2023-03-2110-KStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2022-11-0310-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2022-11-0310-QEmerging growth companyYes
2022-08-0410-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2022-08-0410-QEmerging growth companyYes
2022-05-1210-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2022-05-1210-QEmerging growth companyYes
2022-03-1710-KStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2022-03-1710-KEmerging growth companyYes
2021-11-0410-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2021-11-0410-QEmerging growth companyYes
2021-08-0310-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2021-08-0310-QEmerging growth companyYes
2021-05-0610-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2021-05-0610-QEmerging growth companyYes
2021-03-1910-KStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2021-03-1910-KEmerging growth companyYes
2020-11-0510-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2020-11-0510-QEmerging growth companyYes
2020-08-0410-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2020-08-0410-QEmerging growth companyYes
2020-05-0710-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2020-05-0710-QEmerging growth companyYes
2020-03-1210-KStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2020-03-1210-KEmerging growth companyYes
2019-11-0710-QStock registered under Section 12(b)Common Stock · XFOR · NASDAQ
2019-11-0710-QEmerging growth companyYes
2019-08-0710-QEmerging growth companyYes
2019-05-1510-QEmerging growth companyYes
2019-03-1110-KEmerging growth companyYes
2018-11-0910-QSmaller reporting companyNo
2018-11-0910-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34